First-line Maintenance of OH2 Injection for Advanced Colorectal Cancer
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter, open, randomized controlled Phase II clinical study to
evaluate the efficacy and safety of intratumoral injection of OH2 combined with capecitabine
for first-line maintenance of advanced colorectal cancer.